NPY and prostate carcinoma: Interestingly, we identified many genes differentially regulated in ERG+ prostate cancer, which proteins were previously described as diagnostic or prognostic prostate cancer biomarkers, like AZGP1 [55], [56], APOD [57], [58], CRISP3 [45], NPY [59] and TFF3 [60].